Journal article · 2026 · Open access

GENETIC DETERMINANTS OF DRUG RESPONSE VARIABILITY: A PHARMACOGENOMIC INVESTIGATION

D Suriya, Sridevi Sangeetha K S, Manoj A. Vora, Soundarya Kasi, Laxmidhar Maharana, Amit Kumar, Surendiran Mohan, Lionel John J

Genetics and Molecular Research, 25(1s) · Published 1 January 2026 · DOI 10.4238/v2bk1748

Open PDFView at the publisherCite this paper

In brief

“GENETIC DETERMINANTS OF DRUG RESPONSE VARIABILITY: A PHARMACOGENOMIC INVESTIGATION” is a 2026 journal article by D Suriya and 7 co-authors, published in Genetics and Molecular Research. OpenAlex counts 0 citations as of 21 November 2026. It is open access under a CC BY-SA licence: the full text is free to read at Genetics and Molecular Research.

Citations
0
References
20
Authors
8

Abstract

Individual to individual variance in drugs response is a major issue in clinical therapeutics which may culminate to adverse drug reaction or decreased efficacy. Pharmacogenomics offers a system through which the genetic variations are known to affect drug metabolism, transportation, and interaction with target, hence personalized medicine. The review analyzes the essential hereditary factors of drug response variation, which include in the list of polymorphisms of drug-metabolizing enzymes (e.g., CYP450 family), transporters (ABC and SLC families), and drug targets VKORC1 and EGFR. The up to date findings of pharmacogenomic researches in the cardiovascular, oncological, neurological, and infectious disease are essential to reveal clinically significant drug-gene relationships. Genomic technologies, such as genome-wide association and multi-omics technologies, have led to major improvements in the detection of predictive biomarkers. Also, the accuracy of the prediction of drug responses is being improved with the integration of artificial intelligence and machine learning methods. In spite of these developments, there still are challenges like population bias and limited clinical translation, among others and there are also ethical issues. There is also the assessment of existing clinical guidelines as well as decision-support systems. Visionary perspectives, such as polygenic risk models and precision medicine systems, are presented, which highlights how pharmacogenomics can improve the quality of therapeutic outcomes and promote more personalized treatment plans.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Suriya, D., S, S. S. K., Vora, M. A., Kasi, S., Maharana, L., Kumar, A., Mohan, S., & J, L. J. (2026). GENETIC DETERMINANTS OF DRUG RESPONSE VARIABILITY: A PHARMACOGENOMIC INVESTIGATION. Genetics and Molecular Research, 25(1s). https://doi.org/10.4238/v2bk1748

MLA 9

Suriya, D, et al. “GENETIC DETERMINANTS OF DRUG RESPONSE VARIABILITY: A PHARMACOGENOMIC INVESTIGATION.” Genetics and Molecular Research, vol. 25, no. 1s, 2026. https://doi.org/10.4238/v2bk1748.

Chicago

Suriya, D, Sridevi Sangeetha K S, Manoj A. Vora, Soundarya Kasi, Laxmidhar Maharana, Amit Kumar, Surendiran Mohan, and Lionel John J. 2026. “GENETIC DETERMINANTS OF DRUG RESPONSE VARIABILITY: A PHARMACOGENOMIC INVESTIGATION.” Genetics and Molecular Research 25 (1s). https://doi.org/10.4238/v2bk1748.

Harvard

Suriya, D. et al. (2026) ‘GENETIC DETERMINANTS OF DRUG RESPONSE VARIABILITY: A PHARMACOGENOMIC INVESTIGATION’, Genetics and Molecular Research, 25(1s). doi:10.4238/v2bk1748.

IEEE

D. Suriya et al., “GENETIC DETERMINANTS OF DRUG RESPONSE VARIABILITY: A PHARMACOGENOMIC INVESTIGATION,” Genetics and Molecular Research, vol. 25, no. 1s, 2026, doi: 10.4238/v2bk1748.

BibTeX

@article{suriya2026genetic,
  title     = {{GENETIC DETERMINANTS OF DRUG RESPONSE VARIABILITY: A PHARMACOGENOMIC INVESTIGATION}},
  author    = {Suriya, D and S, Sridevi Sangeetha K and Vora, Manoj A. and Kasi, Soundarya and Maharana, Laxmidhar and Kumar, Amit and Mohan, Surendiran and J, Lionel John},
  journal   = {Genetics and Molecular Research},
  year      = {2026},
  volume    = {25},
  number    = {1s},
  doi       = {10.4238/v2bk1748},
  url       = {https://doi.org/10.4238/v2bk1748}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism

  • pharmacogenomics
  • interindividual drug response variability
  • drug-metabolizing enzymes
  • cytochrome P450 polymorphisms
  • ABC transporters
  • solute carrier transporters
  • VKORC1
  • EGFR

Work with this paper

Most-cited papers in Pharmacology, Toxicology and Pharmaceutics

All highly cited Pharmacology, Toxicology and Pharmaceutics papers

Questions about this paper

How do I cite this paper in APA style?

Suriya, D., S, S. S. K., Vora, M. A., Kasi, S., Maharana, L., Kumar, A., Mohan, S., & J, L. J. (2026). GENETIC DETERMINANTS OF DRUG RESPONSE VARIABILITY: A PHARMACOGENOMIC INVESTIGATION. Genetics and Molecular Research, 25(1s). https://doi.org/10.4238/v2bk1748

How many times has this paper been cited?

0 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Genetics and Molecular Research: sign in and open the PDF from this page.

Who wrote this paper?

D Suriya, Sridevi Sangeetha K S, Manoj A. Vora, Soundarya Kasi, Laxmidhar Maharana, Amit Kumar, Surendiran Mohan, Lionel John J.

What is the DOI of this paper?

10.4238/v2bk1748, permanently at https://doi.org/10.4238/v2bk1748. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.